For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
You are here : Home > Formulary Search > PAD Profile : Alimemazine tartrate - Urticaria
PAD Profile : Alimemazine tartrate - Urticaria
Traffic Light Status
Status 1 of 2.
- Not Specified
Status 2 of 2.
Guidelines
No guidelines returned.
Other Drugs
No drugs returned.
Other Indications
- Sleep disorders in children and adolescents
- Pruritis in eczema
- Sedation in paediatrics for painless procedures
Additional Documents
Committee Recommendations
At the Surrey and North-West Sussex Area Prescribing Committee (APC) held in June 2020, it was decided that all BLACK status drugs would have their review dates extended for 5 years without the need for a review.
If a clinician or provider wishes to change the traffic light status of any BLACK drug then they will need to submit a paper for change as per usual APC process.
The PCN does not recommend Alimemazine for the treatment of Urticaria in children (over the age of 2 years) and adults
Alimemazine will be considered BLACK, for new patients, on the traffic light system
Patients whose treatment with Alimemazine was initiated by the NHS before this recommendation was made, must be reviewed by their prescriber within 6-12 months, but should be able to continue treatment until, the patient and their NHS consultant consider it appropriate to stop.